Overview Clinical Trial Study About Human Adipose-Derived Stem Cells in the Liver Cirrhosis Status: Completed Trial end date: 2018-03-27 Target enrollment: Participant gender: Summary The aim of the investigators study was to investigate the safety and efficacy of autologous ADSCs for the clinical treatment of liver cirrhosis. Phase: Phase 1 Details Lead Sponsor: Gwo Xi Stem Cell Applied Technology Co., Ltd.